Article Details

Antibody–drug conjugates: a breakthrough in the targeted therapy era - BioTechniques

Retrieved on: 2024-06-03 13:35:45

Tags for this article:

Click the tags to see associated articles and topics

Antibody–drug conjugates: a breakthrough in the targeted therapy era - BioTechniques. View article details on hiswai:

Summary

The article discusses the biotechnology behind antibody–drug conjugates (ADCs), their role in targeted cancer therapy, and how companies like Sino Biological contribute to ADC advancement. Tags like 'Antineoplastic drugs' and 'Targeted therapy' emphasize ADCs' potential in precise, effective cancer treatment.

Article found on: www.biotechniques.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up